Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma

xlomafota13 shared this article with you from Inoreader Thyroid-Associated Ophthalmopathy after Radioactive Iodine Therapy for Metastatic Follicular Thyroid Carcinoma Via radioactive iodine Case Rep Endocrinol. 2021 Jun 11;2021:3024639. doi: 10.1155/2021/3024639. eCollection 2021. ABSTRACT Thyroid-associated ophthalmopathy (TAO) is an inflammation of the extraocular muscles and periorbital connective tissue caused by autoantibodies against common antigens to both the thyroid and orbit. The release of antigens and induction of hypothyroidism caused by radioactive iodine (RAI) therapy may exacerbate TAO. Here, we present the case of a 67-year-old-woman treated with RAI therapy for metastatic follicular thyroid carcinoma who presented with TAO during the course of sorafenib administration. Tg and TgAb levels were gradually decreased with sorafenib and lenvatinib treatment, and TAO was improved without any ophthalmologic treatment. PMID:34221517 | PMC:PMC8213507 | DOI:10.1155/2021/3024639 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.